Prostate Cancer Reports


Volume 1 Number 9
 September 2013

Home > Prostate Cancer Reports > Volume 1 - Year 2013 > Number 9, September 2013

CONTENTS


Overviews
Topics
Localized PCa
Locally advanced PCa
Advanced PCa



OVERVIEWS

Bossi A, Briganti A.
Prostate cancer: AUA-ASTRO guidelines for post-RP radiation fail to go nuclear.
Nat Rev Urol. 2013 Sep;10(9):498-9. doi: 10.1038/nrurol.2013.163. Epub 2013 Aug 6.
Abstract | Related citations

TOPICS

Erectile disfunction

Woo SH, Kang DI, Ha YS, Salmasi AH, Kim JH, Lee DH, Kim WJ, Kim IY.
Comprehensive Analysis of Sexual Function Outcome in Prostate Cancer Patients after Robot-Assisted Radical Prostatectomy.
J Endourol. 2013 Aug 30. [Epub ahead of print]
Abstract | Related citations


Gleason score

Penney KL, Stampfer MJ, Jahn JL, Sinnott JA, Flavin R, Rider JR, Finn S, Giovannucci E, Sesso HD, Loda M, Mucci LA, Fiorentino M.
Gleason Grade Progression Is Uncommon.
Cancer Res. 2013 Aug 15;73(16):5163-5168.
Abstract | Related citations


Integrative medicine

Kenfield SA, Dupre N, Richman EL, Stampfer MJ, Chan JM, Giovannucci EL.
Mediterranean Diet and Prostate Cancer Risk and Mortality in the Health Professionals Follow-up Study.
Eur Urol. 2013 Aug 13. doi:pii: S0302-2838(13)00830-0. 10.1016/j.eururo.2013.08.009. [Epub ahead of print]
Abstract | Related citations


Physical activity

Lemanne D, Cassileth B, Gubili J.
The role of physical activity in cancer prevention, treatment, recovery, and survivorship.
Oncology (Williston Park). 2013 Jun;27(6):580-5.
Abstract | Full text | Table | Related citations


Prostate-specific antigen

Wallner LP, Jacobsen SJ.
Prostate-specific antigen and prostate cancer mortality: a systematic review.
Am J Prev Med. 2013 Sep;45(3):318-26. doi: 10.1016/j.amepre.2013.04.015.
Abstract | Full text | Related citations

LOCALIZED PROSTATE CANCER

Active surveillance

Hong SK, Sternberg IA, Keren Paz GE, Kim PH, Touijer KA, Scardino PT, Eastham JA.
Definitive Pathology at Radical Prostatectomy Is Commonly Favorable in Men Following Initial Active Surveillance.
Eur Urol. 2013 Aug 11. doi:pii: S0302-2838(13)00822-1. 10.1016/j.eururo.2013.08.001. [Epub ahead of print]
Abstract | Related citations


Klotz L.
Conservative management for low-risk prostate cancer improves quality-adjusted life expectancy at lower cost compared with initial treatment.
Evid Based Med. 2013 Aug 29. doi: 10.1136/eb-2013-101481. [Epub ahead of print]
Abstract | Full text | Related citations


Functional outcomes

Acar C, Schoffelmeer C, Tillier C, de Blok W, van Muilekom E, van der Poel H.
Quality of Life in patients with low risk prostate cancer A comparative retrospective study (Brachytherapy vs. Robot Assisted Laparoscopic Prostatectomy vs. Active Surveillance).
J Endourol. 2013 Aug 26. [Epub ahead of print]
Abstract | Full text | Related citations


Oncological outcomes

Louis AS, Kalnin R, Maganti M, Pintilie M, Matthew AG, Finelli A, Zlotta AR, Fleshner N, Kulkarni G, Hamilton R, Jewett M, Robinette M, Alibhai SM, Trachtenberg J.
Oncologic outcomes following radical prostatectomy in the active surveillance era.
Can Urol Assoc J. 2013 Jul-Aug;7(7-8):E475-80. doi: 10.5489/cuaj.1404.
Abstract | Full text | Related citations


Recurrence

Lee JW, Ryu JH, Kim YB, Yang SO, Lee JK, Jung TY.
Do positive surgical margins predict biochemical recurrence in all patients without adjuvant therapy after radical prostatectomy?
Korean J Urol. 2013 Aug;54(8):510-5. doi: 10.4111/kju.2013.54.8.510. Epub 2013 Aug 7.
Abstract | Full text | Related citations


Molina Escudero R, Herranz Amo F, Paez Borda A, Hernández Fernández C.
Preoperative predictive model for biochemical recurrence in patients with localized prostate cancer treated with radical prostatectomy.
Arch Esp Urol. 2013 Jul;66(6):567-575.
Abstract | Related citations


Survival

Johnson SB, Hamstra DA, Jackson WC, Zhou J, Foster B, Foster C, Song Y, Li D, Palapattu GS, Kunju L, Mehra R, Sandler H, Feng FY.
Larger maximum tumor diameter at radical prostatectomy is associated with increased biochemical failure, metastasis, and death from prostate cancer after salvage radiation for prostate cancer.
Int J Radiat Oncol Biol Phys. 2013 Oct 1;87(2):275-81. doi: 10.1016/j.ijrobp.2013.05.043. Epub 2013 Jul 23.
Abstract | Related citations


Treatment

Bolla M.
Words of wisdom: Re: High-risk prostate cancer treated with pelvic radiotherapy and 36 versus 18 months of androgen blockade: results of a phase III randomized study [abstract 3].
Eur Urol. 2013 Sep;64(3):513. doi: 10.1016/j.eururo.2013.06.028.
Abstract | Full text | Related citations


Pfister D, Bolla M, Briganti A, Carroll P, Cozzarini C, Joniau S, van Poppel H, Roach M, Stephenson A, Wiegel T, Zelefsky MJ.
Early salvage radiotherapy following radical prostatectomy.
Eur Urol. 2014 Jun;65(6):1034-43. doi: 10.1016/j.eururo.2013.08.013. Epub 2013 Aug 15.
Abstract | Full text | Related citations


Tai HC, Lai MK, Huang CY, Wang SM, Huang KH, Chen CH, Chung SD, Chueh SC, Yu HJ, Pu YS.
Laparoscopic radical prostatectomy monotherapy, a more aggressive yet less invasive option, is oncologically effective in selected men with high-risk prostate cancer having only one D'Amico risk factor: Experience from an Asian tertiary referral center.
J Endourol. 2013 Aug 30. [Epub ahead of print]
Abstract | Related citations


Treatment comparison



Sun M, Sammon JD, Becker A, Roghmann F, Tian Z, Kim SP, Larouche A, Abdollah F, Hu JC, Karakiewicz PI, Trinh QD.
Radical prostatectomy vs radiotherapy vs observation among older patients with clinically localized prostate cancer: a comparative effectiveness evaluation.
BJU Int. 2013 Jun 20. doi: 10.1111/bju.12321. [Epub ahead of print]
Abstract | Related citations


Treatment complications

Yossepowitch O, Briganti A, Eastham JA, Epstein J, Graefen M, Montironi R, Touijer K.
Positive Surgical Margins After Radical Prostatectomy: A Systematic Review and Contemporary Update.
Eur Urol. 2013 Aug 3. doi:pii: S0302-2838(13)00796-3. 10.1016/j.eururo.2013.07.039. [Epub ahead of print]
Abstract | Full text | Related citations

LOCALLY ADVANCED PROSTATE CANCER


Treatment

Prezioso D, Iacono F, Romeo G, Ruffo A, Russo N, Illiano E.
Early versus delayed hormonal treatment in locally advanced or asymptomatic metastatic prostatic cancer patient dilemma.
World J Urol. 2013 Aug 8. [Epub ahead of print]
Abstract | Related citations

ADVANCED PROSTATE CANCER


Treatment

Reyes D, Salazar L, Espinoza E, Pereda C, Castellón E, Valdevenito R, Huidobro C, Inés Becker M, Lladser A, López MN, Salazar-Onfray F.
Tumour cell lysate-loaded dendritic cell vaccine induces biochemical and memory immune response in castration-resistant prostate cancer patients.
Br J Cancer. 2013 Sep 17;109(6):1488-97. doi: 10.1038/bjc.2013.494. Epub 2013 Aug 29.
Abstract | Related citations


Sun L, Lü JJ.
Controversies in the treatments of prostate cancer.
Chin Med J (Engl). 2013 Aug;126(15):2972-7.
Abstract | Full text | Related citations